Synthesis and evaluation of new Furanyl and Thiophenyl azoles as antileishmanial agents

Show simple item record

dc.contributor.author Marrapu, V K
dc.contributor.author Mittal, Monika
dc.contributor.author Shivahare, Rahul
dc.contributor.author Gupta, Suman
dc.contributor.author Bhandari, Kalpana
dc.date.accessioned 2011-07-20T09:30:19Z
dc.date.available 2011-07-20T09:30:19Z
dc.date.issued 2011
dc.identifier.citation European Journal of medicinal Chemistry (2011), 46(5), 1694-1700 en
dc.identifier.uri http://hdl.handle.net/123456789/704
dc.description.abstract A series of benzyloxy furanyl and benzyloxy thiophenyl azoles were synthesized and screened for their in vitro antileishmanial activity against Leishmania donovani. Among all, 16 compounds have shown more than 90% inhibition against promastigotes at 20 µM while 11 compounds exhibited IC50 in the range of 3.04-9.39 µM against amastigotes. Compound 4, a 3-chlorobenzyloxy furanyl imidazole emerged as the most active compound in the series with IC50 value of 3.04 µM and SI value of 19.80, and was several folds more potent than the reference drugs miltefosine and miconazole. en
dc.format.extent 309744 bytes
dc.format.mimetype application/pdf
dc.language.iso en en
dc.relation.ispartofseries cdricommunicationno.8022 en
dc.subject Antileishmanial en
dc.subject miconazole en
dc.subject azoles en
dc.subject sterol biosynthesis inhibitors (SBIs) en
dc.title Synthesis and evaluation of new Furanyl and Thiophenyl azoles as antileishmanial agents en
dc.type Article en


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account